5 Chapter 7FIGURE 7.1 (a) The proposed secondary structure model of SMCTs. The 13 putat...FIGURE 7.2 The phylogenetic tree of human MCT family members. The bar indica...FIGURE 7.3 Lactate shuttling pathway in glycolytic and oxidative cancer cell...
6 Chapter 8FIGURE 8.1 Core chemical structures of a purine nucleoside (a) and a pyrimid...FIGURE 8.2 Substrate selectivity and localization of hCNTs and hENTs in pola...FIGURE 8.3 Membrane topology and secondary structure of hCNT3 (a) and hENT1 ...
7 Chapter 9FIGURE 9.1 Bile acid synthesis. Primary bile acids, cholic acid (CA), and ch...FIGURE 9.2 The enterohepatic circulation (EHC) of bile acids. Bile acids are...
8 Chapter 10FIGURE 10.1 Atomic structures of human P‐gp solved with ligand bound in the ...FIGURE 10.2 Proposed transport cycle of P‐gp. The ligand (in this case pacli...FIGURE 10.3 Chemical structures of selected repurposed drugs used as modulat...
9 Chapter 11FIGURE 11.1 (a) Topology of the “long” human ABBC/MRP subfamily members ABCC...FIGURE 11.2 Expression of ABCC/MRP transporters in 32 human cancers from the...
10 Chapter 12FIGURE 12.1 Structural characterization of ABCG2. (a) ATP‐hydrolysis‐depende...FIGURE 12.2 Expression of ABCG2 and ABCB1 in tumor samples. Data retrieved f...
11 Chapter 13FIGURE 13.1 In vivo architecture of the liver (a)and localization of sel...
12 Chapter 14FIGURE 14.1 Localization of selective ABC and SLC transporters at the blood–...FIGURE 14.2 Localization of selective ABC and SLC transporters in neurons, m...
13 Chapter 15FIGURE 15.1 Schematic representation of the basic functional unit of the kid...
14 Chapter 16FIGURE 16.1 Schematic overview of clinically relevant ATP‐binding cassette (...FIGURE 16.2 Mean relative protein abundance of clinically relevant intestina...FIGURE 16.3 Different possible scenarios of intestinal drug–drug interaction...
15 Chapter 17FIGURE 17.1 A schematic illustration of cellular localization of major drug ...
16 Chapter 20FIGURE 20.1 Schematic diagram for transcellular transport study in polarized...
17 Chapter 21FIGURE 21.1 Relationship between rat biliary excretion (%) and physicochemic...FIGURE 21.2 Principal component analysis of compounds with rat biliary excre...FIGURE 21.3 Physicochemical trends of human renal clearance. Relationship be...FIGURE 21.4 (a) Extended clearance classification system (ECCS) and the majo...FIGURE 21.5 View of the distance of partial residues of P‐gp‐MDR1 the interf...FIGURE 21.6 Schematic depiction of ECCS‐informed approach for ADCE and pharm...FIGURE 21.7 Structures and pharmacological activity of systemic and hepatose...FIGURE 21.8 Structures of third‐generation P‐gp inhibitor tariquidar and the...
18 Chapter 22FIGURE 22.1 Schematic diagram of the methods for estimating the contribution...FIGURE 22.2 Contribution of each transporter isoform to the overall uptake o...FIGURE 22.3 Comparison of pharmacokinetic parameters for several compounds o...FIGURE 22.4 Comparison between the uptake clearance (f B PS u,inf ) at 0% HS...FIGURE 22.5 Relationship between the observed and predicted renal uptake cle...FIGURE 22.6 Substrate dependence of IC 50 values of OATP1B1 inhibitors (cycl...FIGURE 22.7 Structures of physiologically based pharmacokinetic models of ri...
19 Chapter 23FIGURE 23.1 Schematic depicting the central role of IVIVE ( in vitro—in vivo ...FIGURE 23.2 The schematic provides examples of key permeability‐limited orga...FIGURE 23.3 Part (a) is a schematic of the PBPK/PD model accounting for the ...
20 Chapter 25FIGURE 25.1 Structure of common isothiocyanates.
1 Cover Page
2 Series Page Wiley Series in Drug Discovery and Development Binghe Wang, Series Editor A complete list of the titles in this series appears at the end of this volume
3 DRUG TRANSPORTERS
4 Copyright Page
5 Dedication Page
6 LIST OF CONTRIBUTORS
7 PREFACE
8 Table of Contents
9 Begin Reading
10 Index
11 Wiley Series in Drug Discovery and Development
12 WILEY END USER LICENSE AGREEMENT
1 ii
2 iii
3 iv
4 v
5 xix
6 xx
7 xxi
8 xxii
9 1
10 2
11 3
12 4
13 5
14 6
15 7
16 9
17 10
18 11
19 12
20 13
21 14
22 15
23 16
24 17
25 18
26 19
27 20
28 21
29 22
30 23
31 24
32 25
33 26
34 27
35 28
36 29
37 30
38 31
39 32
40 33
41 34
42 35
43 36
44 37
45 38
46 39
47 40
48 41
49 42
50 43
51 44
52 45
53 46
54 47
55 48
56 49
57 50
58 51
59 52
60 53
61 54
62 55
63 57
64 58
65 59
66 60
67 61
68 62
69 63
70 64
71 65
72 66
73 67
74 68
75 69
76 70
77 71
78 72
79 73
80 74
81 75
82 76
83 77
84 79
85 80
86 81
87 82
88 83
89 84
90 85
91 86
92 87
93 88
94 89
95 90
96 91
97 92
98 93
99 94
100 95
101 96
102 97
103 98
104 99
105 100
106 101
107 102
108 103
109 104
110 105
111 106
112 107
113 108
114 109
115 110
116 111
117 112
118 113
119 115
120 116
121 117
122 118
123 119
124 120
125 121
126 122
127 123
128 124
129 125
130 126
131 127
132 128
133 129
134 130
135 131
136 132
137 133
138 134
139 135
140 136
141 137
142 138
143 139
144 140
145 141
146 142
147 143
148 144
149 145
150 146
151 147
152 148
153 149
154 150
155 151
156 152
157 153
158 154
159 155
160 156
161 157
162 158
163 159
164 160
165 161
166 162
167 163
168 164
169 165
170 166
171 167
172 168
173 169
174 170
175 171
176 172
177 173
178 174
179 175
180 176
181 177
182 178
183 179
184 180
185 181
186 182
187 183
188 184
189 185
190 186
191 187
192 189
193 190
194 191
195 192
196 193
197 194
198 195
199 196
200 197
201 198
202 199
203 200
204 201
205 202
206 203
207 204
208 205
209 206
210 207
211 208
212 209
213 213
214 214
215 215
216 216
217 217
218 218
219 219
220 220
221 221
222 222
223 223
224 224
225 225
226 226
227 227
228 228
229 229
230 230
231 231
232 232
233 233
234 235
235 236
236 237
237 238
238 239
239 240
240 241
241 242
242 243
243 244
244 245
245 246
246 247
247 248
248 249
249 250
250 251
251 252
252 253
253 254
254 255
255 256
256 257
257 258
258 259
259 260
260 261
261 262
262 263
263 264
264 265
265 266
266 267
Читать дальше